Showing 1 - 10 of 946
I use the Medicare Part D prescription drug insurance market to examine the dynamics of firm interaction with consumers …
Persistent link: https://www.econbiz.de/10010821994
estimates to evaluate the effects of hospital mergers. We find that MCO bargaining restrains hospital prices significantly. The … model demonstrates the potential impact of coinsurance rates, which allow MCOs to partly steer patients towards cheaper … hospitals. We show that increasing patient coinsurance tenfold would reduce prices by 16%. We find that a proposed hospital …
Persistent link: https://www.econbiz.de/10010796731
This paper seeks to understand the impact of the Medicare Rural Hospital Flexibility (Flex) Program on rural resident … hospital choice and welfare. The Flex program created a new class of hospital, the Critical Access Hospital (CAH), which … receives more generous reimbursement in return for limits on capacity and length of stay. A hospital that converted to CAH …
Persistent link: https://www.econbiz.de/10010630687
both universally licensed and provide complementary services to patients, but may also be substitutes as service providers …
Persistent link: https://www.econbiz.de/10008727871
We examine the impact of loss of U.S. patent exclusivity (LOE) on the prices and utilization of specialty drugs between 2001 and 2007. We limit our empirical cohort to drugs commonly used to treat cancer and base our analyses on nationally representative data from IMS Health. We begin by...
Persistent link: https://www.econbiz.de/10010950850
On January 1, 2006, the federal government began providing insurance coverage for Medicare recipients' prescription … drug expenditures through a new program known as Medicare Part D. Rather than setting pharmaceutical prices itself, the … Medicare recipient allowed to choose from one of the private insurers with a contract to offer coverage in her geographic …
Persistent link: https://www.econbiz.de/10005774476
The federal-state Medicaid program insures 43 million people for virtually all of the prescription drugs approved by the FDA. To determine the price that it will pay for a drug treatment, the government uses the average price in the private sector for that same drug. Assuming that Medicaid...
Persistent link: https://www.econbiz.de/10005778002
regarding the impact of the 2006 implementation of the Medicare Part D benefits on pharmaceutical prices and utilization, and …
Persistent link: https://www.econbiz.de/10008531891
The US Food and Drug Administration (FDA) expends considerable efforts in regulating medications approved for use. Yet the impact of medication labeling changes on brand pharmaceutical products, and whether and what firms do to respond to increased information regarding the safety and efficacy...
Persistent link: https://www.econbiz.de/10009325511
influencing the size and bargaining power of health insurers. We test for this external effect in the context of Medicare Part D …
Persistent link: https://www.econbiz.de/10008611557